Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free CTRE Stock Alerts

CareTrust REIT (CTRE) Financials

CareTrust REIT logo
$41.97 -0.47 (-1.12%)
As of 02:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for CareTrust REIT

Annual Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 10 29 26 58 46 81 72 -7.51 54 125 321
Consolidated Net Income / (Loss)		 10 29 26 58 46 81 72 -7.51 54 124 320
Net Income / (Loss) Continuing Operations		 10 29 26 58 46 81 72 -7.51 54 124 320
Total Pre-Tax Income 		10 29 26 58 46 81 72 -7.51 54 124 325
Total Operating Income		 33 52 47 84 73 105 107 25 80 82 218
Total Gross Profit		 74 102 130 154 161 176 192 182 199 229 381
Total Revenue		 74 105 133 157 163 178 192 188 199 229 381
Operating Revenue		 74 105 133 157 163 178 192 188 199 229 381
Total Cost of Revenue		 0.00 2.55 2.73 2.96 2.90 1.87 0.00 5.04 0.00 0.00 0.00
Total Operating Expenses		 41 50 84 70 88 72 86 158 119 148 163
Selling, General & Admin Expense		 7.66 9.30 11 13 15 16 27 20 22 29 53
Depreciation Expense		 24 32 39 46 52 53 55 50 51 57 93
Other Operating Expenses / (Income)		 9.08 8.17 33 12 4.12 2.84 3.57 8.18 9.59 20 14
Impairment Charge		 0.00 0.00 0.89 0.00 17 0.00 0.00 79 36 42 2.48
Total Other Income / (Expense), net		 -23 -23 -21 -26 -26 -24 -35 -32 -26 43 107
Interest Expense		 24 23 24 28 28 24 35 30 41 31 44
Interest & Investment Income		 0.97 0.00 3.54 - - - - 8.63 19 67 95
Other Income / (Expense), net		 0.00 -0.27 0.00 2.05 1.78 -0.04 -0.08 -11 -4.27 6.84 56
Income Tax Expense		 - - - - - - - - 0.00 0.00 5.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - 0.00 0.00 -0.01 -0.68 -0.25
Basic Earnings per Share		 $0.26 $0.52 $0.35 $0.73 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.81 $1.57
Weighted Average Basic Shares Outstanding		 37.38M 56.03M 72.65M 79.39M 93.09M 95.20M 96.02M 96.70M 105.96M 154.80M 203.64M
Diluted Earnings per Share		 $0.26 $0.52 $0.35 $0.72 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.80 $1.57
Weighted Average Diluted Shares Outstanding		 37.38M 56.03M 72.65M 79.39M 93.10M 95.21M 96.09M 96.70M 106.15M 155.17M 204.09M
Weighted Average Basic & Diluted Shares Outstanding		 48.15M 66.22M 76.14M 88.85M 95.47M 95.89M 97.05M 99.51M 130.50M 187.66M 223.40M
Cash Dividends to Common per Share		 $0.64 $0.68 $0.74 $0.82 $0.90 $1.00 $1.06 $1.10 $1.12 $1.16 $1.34

Quarterly Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 8.70 26 29 11 33 52 66 69 75 111 80
Consolidated Net Income / (Loss)		 8.69 26 29 10 33 52 65 68 75 112 80
Net Income / (Loss) Continuing Operations		 8.69 26 29 10 33 52 65 68 75 111 80
Total Pre-Tax Income 		8.69 26 29 10 33 52 65 69 77 113 82
Total Operating Income		 26 14 28 7.47 22 -20 45 52 61 59 71
Total Gross Profit		 55 40 53 55 54 19 74 88 107 112 121
Total Revenue		 56 41 54 55 57 20 74 89 107 110 121
Operating Revenue		 56 41 54 55 57 20 74 89 107 110 121
Total Cost of Revenue		 1.24 0.56 0.66 0.26 3.48 1.32 0.00 0.94 0.28 -1.32 0.00
Total Operating Expenses		 29 26 25 48 31 38 30 36 45 52 50
Selling, General & Admin Expense		 5.52 6.51 6.84 6.14 6.66 9.29 9.02 13 15 16 17
Depreciation Expense		 13 13 13 14 14 16 18 21 27 27 29
Other Operating Expenses / (Income)		 2.17 1.73 1.80 1.98 2.12 8.17 3.06 2.12 2.89 6.89 2.96
Total Other Income / (Expense), net		 -17 13 0.74 2.95 11 72 21 17 16 54 11
Interest Expense		 12 8.27 8.23 8.68 8.94 5.12 6.67 13 13 11 11
Interest & Investment Income		 - - 9.57 13 20 - 22 24 25 24 22
Other Income / (Expense), net		 -5.25 1.63 -0.60 -1.86 -0.49 9.78 5.16 6.38 3.31 41 0.06
Income Tax Expense		 - - - 0.00 0.00 - 0.00 1.03 2.08 - 2.27
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.01 -0.00 0.00 -0.34 -0.17 -0.18 -0.61 -0.64 0.03 0.97 -0.71
Basic Earnings per Share		 $0.08 $0.24 $0.22 $0.07 $0.21 $0.31 $0.35 $0.36 $0.35 $0.51 $0.36
Weighted Average Basic Shares Outstanding		 104.01M 105.96M 132.84M 144.90M 159.46M 154.80M 187.15M 192.44M 211.75M 203.64M 223.01M
Diluted Earnings per Share		 $0.08 $0.24 $0.22 $0.07 $0.21 $0.30 $0.35 $0.35 $0.35 $0.52 $0.36
Weighted Average Diluted Shares Outstanding		 104.31M 106.15M 133.20M 145.26M 159.85M 155.17M 187.42M 192.85M 212.27M 204.09M 223.96M
Weighted Average Basic & Diluted Shares Outstanding		 119.11M 130.50M 142.06M 154.21M 171.45M 187.66M 191.69M 200.30M 223.30M 223.40M 236.24M
Cash Dividends to Common per Share		 $0.28 - $0.29 $0.29 $0.29 - $0.34 $0.34 $0.34 - $0.39

Annual Cash Flow Statements for CareTrust REIT

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -14 -3.97 -0.59 30 -16 -1.41 0.98 -6.72 281 -81 -16
Net Cash From Operating Activities		 40 64 89 99 126 146 157 144 155 244 394
Net Cash From Continuing Operating Activities		 40 64 89 99 126 146 157 144 155 244 394
Net Income / (Loss) Continuing Operations		 10 29 26 58 46 81 72 -7.51 54 124 320
Consolidated Net Income / (Loss)		 10 29 26 58 46 81 72 -7.51 54 124 320
Depreciation Expense		 24 32 39 46 52 53 55 50 51 57 93
Amortization Expense		 2.20 2.24 2.10 1.94 2.00 1.95 2.05 2.10 2.05 -0.05 -2.47
Non-Cash Adjustments To Reconcile Net Income		 1.79 1.25 26 -0.77 30 5.10 22 100 45 43 -43
Changes in Operating Assets and Liabilities, net		 2.10 -0.39 -4.42 -5.51 -4.08 5.00 5.89 -0.32 2.39 20 26
Net Cash From Investing Activities		 -235 -285 -303 -115 -316 -42 -193 -127 -268 -1,514 -1,461
Net Cash From Continuing Investing Activities		 -235 -285 -303 -115 -316 -42 -193 -127 -268 -1,514 -1,461
Purchase of Property, Plant & Equipment		 -233 -281 -0.40 -9.01 -6.29 -8.30 -6.01 -7.29 -11 -8.05 -15
Acquisitions		 -1.75 -5.36 -297 -117 -321 -3.00 0.00 0.00 -5.58 -869 -174
Purchase of Investments		 0.00 0.00 - - - -30 -1.25 -150 -60 -96 -97
Sale of Property, Plant & Equipment		 - 2.86 0.00 13 3.50 6.61 6.96 45 16 14 79
Other Investing Activities, net		 -0.19 -0.76 -13 -2.42 6.04 -8.72 -192 -16 -207 -555 -1,254
Net Cash From Financing Activities		 181 216 213 46 173 -106 37 -24 394 1,189 1,051
Net Cash From Continuing Financing Activities		 181 216 213 46 173 -106 37 -24 394 1,189 1,051
Repayment of Debt		 -40 -301 -442 -135 -383 -75 -504 -120 -310 -284 -911
Payment of Dividends		 -22 -37 -53 -63 -81 -93 -101 -106 -116 -172 -265
Issuance of Debt		 80 355 538 65 443 65 620 160 185 75 1,150
Issuance of Common Equity		 163 200 170 180 196 -0.40 23 47 636 1,573 1,080
Other Financing Activities, net		 -0.15 -0.52 -0.87 -1.29 -2.52 -2.00 -1.33 -4.47 -1.48 -2.48 -3.33
Effect of Exchange Rate Changes		 - - - - - - - - 0.00 0.00 0.52
Cash Interest Paid		 22 21 30 26 26 22 23 26 40 28 40

Quarterly Cash Flow Statements for CareTrust REIT

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 2.34 291 157 44 -118 -163 419 -326 406 -514 25
Net Cash From Operating Activities		 45 43 49 53 67 75 71 101 101 121 90
Net Cash From Continuing Operating Activities		 45 43 49 53 67 75 71 101 101 121 90
Net Income / (Loss) Continuing Operations		 8.69 26 29 10 33 52 65 68 75 112 80
Consolidated Net Income / (Loss)		 8.69 26 29 10 33 52 65 68 75 112 80
Depreciation Expense		 13 13 13 14 14 16 18 21 27 27 29
Amortization Expense		 0.61 0.23 0.04 1.19 -1.34 0.06 0.04 0.06 -3.65 1.09 1.17
Non-Cash Adjustments To Reconcile Net Income		 15 4.66 5.05 26 9.20 2.76 -3.15 -0.38 -4.53 -35 -2.48
Changes in Operating Assets and Liabilities, net		 8.07 -1.74 1.52 1.05 12 4.87 -8.56 12 7.42 15 -17
Net Cash From Investing Activities		 -56 -36 -123 -345 -359 -686 -36 -789 -76 -560 -105
Net Cash From Continuing Investing Activities		 -56 -36 -123 -345 -359 -686 -36 -789 -76 -560 -105
Purchase of Property, Plant & Equipment		 -2.76 -1.84 -0.40 -0.93 -2.87 -3.86 -2.28 -4.51 -3.23 -4.98 -3.16
Acquisitions		 -202 -37 -4.11 -219 166 -0.39 -36 5.05 -5.36 -138 -0.15
Purchase of Investments		 -23 -9.63 -52 -193 -260 -150 -6.39 -15 -27 -49 -31
Sale of Property, Plant & Equipment		 - 1.85 0.05 0.09 4.94 8.86 44 - - 35 0.00
Other Investing Activities, net		 173 11 -67 67 -267 -540 -36 -775 -40 -404 -71
Net Cash From Financing Activities		 13 284 231 336 174 447 383 362 381 -75 41
Net Cash From Continuing Financing Activities		 13 284 231 336 174 447 383 362 381 -75 41
Repayment of Debt		 -310 -0.05 -0.02 - -275 -8.79 -0.14 -529 -382 - 0.00
Payment of Dividends		 -28 -32 -37 -41 -45 -50 -55 -64 -69 -77 -77
Issuance of Debt		 30 - 0.00 75 - - 425 600 125 - 0.00
Issuance of Common Equity		 321 316 270 303 494 506 17 355 707 1.44 128
Other Financing Activities, net		 - - -2.48 - - -0.00 -3.33 - - - -10
Effect of Exchange Rate Changes		 - - - - - - 0.00 - 0.02 0.18 -0.48
Cash Interest Paid		 7.54 11 3.77 12 4.63 8.01 0.45 16 9.33 14 6.24

Annual Balance Sheets for CareTrust REIT

This table presents CareTrust REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 673 925 1,185 1,292 1,519 1,504 1,641 1,621 2,085 3,437 5,148
Total Current Assets		 16 15 13 57 34 31 30 25 318 347 531
Cash & Equivalents		 11 7.50 6.91 37 20 19 20 13 294 214 198
Note & Lease Receivable		 - - - - - - - - 0.00 96 92
Accounts Receivable		 2.34 5.90 5.25 11 2.57 1.82 2.42 0.42 0.40 1.17 10
Prepaid Expenses		 2.08 1.37 0.90 8.67 11 10 7.51 12 23 36 230
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,421 1,567 0.00 3,710
Total Noncurrent Assets		 657 911 1,172 1,235 1,485 1,472 1,611 174 200 3,090 908
Long-Term Investments		 8.48 14 18 18 33 15 15 156 180 795 899
Other Noncurrent Operating Assets		 649 897 1,154 1,217 1,452 1,457 1,596 18 19 2,295 8.57
Total Liabilities & Shareholders' Equity		 673 925 1,185 1,292 1,519 1,504 1,641 1,621 2,085 3,437 5,148
Total Liabilities		 411 473 590 524 591 589 725 771 666 508 1,089
Total Current Liabilities		 17 23 31 34 15 20 25 52 71 56 120
Accounts Payable		 9.27 12 17 16 15 20 25 24 34 56 120
Total Noncurrent Liabilities		 394 450 559 490 576 570 700 719 596 451 969
Long-Term Debt		 394 450 559 490 555 546 673 719 596 397 894
Other Noncurrent Operating Liabilities		 - - - - 22 24 26 - - 54 75
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - - - 0.00 18 18
Total Equity & Noncontrolling Interests		 262 452 595 768 928 914 916 849 1,419 2,911 4,041
Total Preferred & Common Equity		 262 452 595 768 928 914 916 849 1,417 2,908 4,035
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 262 452 595 768 928 914 916 849 1,417 2,908 4,035
Common Stock		 411 612 784 966 1,164 1,165 1,198 1,246 1,884 3,441 4,521
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - - - 0.00 5.87
Other Equity Adjustments		 -148 -160 -189 -198 -236 -251 -282 -397 -468 -533 -492
Noncontrolling Interest		 - - - - - - - 0.00 1.90 2.72 5.53

Quarterly Balance Sheets for CareTrust REIT

This table presents CareTrust REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 1,646 1,622 1,737 1,768 2,348 2,699 2,921 3,884 4,657 5,089 5,237
Total Current Assets		 25 58 16 25 479 527 412 199 494 908 421
Cash & Equivalents		 4.86 28 1.15 3.49 451 495 377 27 306 712 223
Note & Lease Receivable		 - - - - - - - 97 97 98 93
Accounts Receivable		 0.81 0.44 0.39 0.38 0.40 1.10 0.88 1.95 2.69 7.39 14
Prepaid Expenses		 19 30 14 21 28 31 34 74 88 90 91
Plant, Property, & Equipment, net		 1,384 0.00 1,528 1,536 1,619 1,706 1,749 2,252 0.00 3,272 3,877
Total Noncurrent Assets		 237 1,564 193 207 250 466 760 1,433 4,162 909 939
Long-Term Investments		 159 141 167 181 233 434 741 800 841 871 932
Other Noncurrent Operating Assets		 78 1,423 26 26 16 32 19 633 3,321 37 7.87
Total Liabilities & Shareholders' Equity		 1,646 1,622 1,737 1,768 2,348 2,699 2,921 3,884 4,657 5,089 5,237
Total Liabilities		 832 782 924 657 672 753 496 936 1,332 1,072 1,083
Total Current Liabilities		 58 24 329 61 76 82 99 114 109 178 100
Accounts Payable		 31 24 21 29 35 37 50 51 109 103 100
Total Noncurrent Liabilities		 774 758 595 595 596 671 397 822 1,222 894 983
Long-Term Debt		 774 730 595 595 596 671 397 822 996 894 895
Other Noncurrent Operating Liabilities		 - 28 - - - - - - 226 - 89
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - - 17 21 18 16
Total Equity & Noncontrolling Interests		 814 840 813 1,111 1,676 1,946 2,425 2,931 3,304 3,999 4,138
Total Preferred & Common Equity		 814 840 813 1,110 1,674 1,944 2,422 2,927 3,301 3,994 4,132
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 813 840 813 1,110 1,674 1,944 2,422 2,927 3,301 3,994 4,132
Common Stock		 1,197 1,246 1,247 1,567 2,154 2,458 2,953 3,457 3,810 4,519 4,641
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - - 19 3.71 -8.97
Other Equity Adjustments		 -384 -405 -434 -457 -480 -514 -530 -530 -528 -528 -500
Noncontrolling Interest		 - - - 1.06 2.30 2.08 2.54 3.47 3.51 4.57 6.57

Annual Metrics And Ratios for CareTrust REIT

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 25.62% 41.48% 27.04% 18.02% 4.12% 9.14% 7.86% -2.52% 5.92% 15.44% 66.14%
EBITDA Growth		 261.18% 45.41% 1.58% 52.04% -3.86% 24.11% 2.91% -59.53% 94.04% 12.81% 150.96%
EBIT Growth		 506.69% 57.70% -10.90% 84.35% -13.17% 40.34% 1.87% -86.97% 443.63% 17.12% 210.02%
NOPAT Growth		 680.99% 58.50% -11.35% 79.95% -13.17% 43.82% 1.91% -83.74% 360.09% 2.27% 163.52%
Net Income Growth		 223.22% 192.54% -11.85% 123.87% -19.96% 74.44% -10.99% -110.43% 815.72% 131.56% 157.47%
EPS Growth		 172.22% 100.00% -32.69% 105.71% -31.94% 73.47% -12.94% -110.81% 725.00% 60.00% 96.25%
Operating Cash Flow Growth		 83.76% 60.06% 37.82% 11.89% 27.11% 15.39% 7.64% -7.94% 7.17% 57.82% 61.32%
Free Cash Flow Firm Growth		 -780.70% -11.34% -4.57% 102.69% -2,558.06% 179.55% -120.24% 765.38% -148.05% -928.21% -100.65%
Invested Capital Growth		 47.92% 38.50% 28.13% 6.85% 17.01% -0.19% 9.00% -8.19% 10.45% 50.48% 66.40%
Revenue Q/Q Growth		 8.17% 7.07% 6.55% 37.23% -17.68% -0.05% 3.28% -3.63% -5.36% -14.79% 14.13%
EBITDA Q/Q Growth		 96.38% -6.66% -10.23% 66.77% -19.99% -0.46% -0.83% -14.45% -5.59% -22.57% 27.85%
EBIT Q/Q Growth		 490.43% -12.81% -21.05% 161.01% -31.09% -0.90% -2.01% -39.59% -10.23% -33.50% 32.22%
NOPAT Q/Q Growth		 490.43% -12.37% -21.05% 171.72% -32.60% 0.57% -2.09% -16.57% -15.21% -39.24% 17.69%
Net Income Q/Q Growth		 77.19% 13.04% -19.17% 29.77% 12.42% 0.49% -3.74% -107.06% 28.50% 25.99% 23.20%
EPS Q/Q Growth		 36.84% 8.33% -27.08% 28.57% 6.52% 1.19% -3.90% -100.00% 21.95% 8.11% 16.30%
Operating Cash Flow Q/Q Growth		 19.84% 6.09% 8.49% 5.41% 3.41% 4.45% 0.74% -3.19% 6.12% 15.37% 13.14%
Free Cash Flow Firm Q/Q Growth		 0.00% -112.25% 9.15% 107.98% -5.84% -20.52% 61.73% 13.42% -684.70% -996.65% 9.71%
Invested Capital Q/Q Growth		 -1.33% 10.84% 4.98% 2.77% 0.37% 2.41% -0.24% -1.68% 1.41% 35.27% 13.34%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 97.56% 97.94% 98.11% 98.23% 98.95% 100.00% 97.31% 98.28% 97.51% 100.00%
EBITDA Margin		 80.35% 82.58% 66.03% 85.07% 78.55% 89.33% 85.23% 35.39% 64.83% 63.35% 95.69%
Operating Margin		 44.76% 50.14% 34.99% 53.35% 44.50% 58.64% 55.40% 13.20% 40.13% 35.55% 57.27%
EBIT Margin		 44.76% 49.89% 34.99% 54.66% 45.58% 58.61% 55.36% 7.40% 37.98% 38.54% 71.91%
Profit (Net Income) Margin		 13.56% 28.04% 19.46% 36.91% 28.37% 45.35% 37.42% -4.00% 27.05% 54.26% 84.08%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.46%
Interest Burden Percent		 30.30% 56.20% 55.60% 67.52% 62.24% 77.36% 67.60% -54.09% 71.22% 140.80% 118.76%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.54%
Return on Invested Capital (ROIC)		 6.14% 6.84% 4.57% 7.08% 5.49% 7.33% 7.15% 1.16% 5.31% 4.13% 6.96%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.43% 1.20% 0.39% 1.93% -0.04% 2.65% 1.14% -2.92% -1.76% -17.29% -18.92%
Return on Net Nonoperating Assets (RNNOA)		 -0.80% 1.38% 0.37% 1.42% -0.02% 1.46% 0.72% -2.01% -0.57% 1.59% 2.21%
Return on Equity (ROE)		 5.34% 8.21% 4.94% 8.50% 5.47% 8.78% 7.87% -0.85% 4.74% 5.72% 9.17%
Cash Return on Invested Capital (CROIC)		 -32.52% -25.45% -20.09% 0.46% -10.18% 7.52% -1.46% 9.70% -4.63% -36.18% -42.89%
Operating Return on Assets (OROA)		 5.77% 6.53% 4.41% 6.93% 5.30% 6.92% 6.77% 0.85% 4.07% 3.20% 6.38%
Return on Assets (ROA)		 1.75% 3.67% 2.45% 4.68% 3.30% 5.35% 4.58% -0.46% 2.90% 4.51% 7.46%
Return on Common Equity (ROCE)		 5.34% 8.21% 4.94% 8.50% 5.47% 8.78% 7.87% -0.85% 4.73% 5.69% 9.11%
Return on Equity Simple (ROE_SIMPLE)		 3.83% 6.49% 4.35% 7.54% 5.00% 8.85% 7.86% -0.88% 3.79% 4.28% 0.00%
Net Operating Profit after Tax (NOPAT)		 33 52 47 84 73 105 107 17 80 82 215
NOPAT Margin		 44.76% 50.14% 34.99% 53.35% 44.50% 58.64% 55.40% 9.24% 40.13% 35.55% 56.39%
Net Nonoperating Expense Percent (NNEP)		 6.56% 5.64% 4.18% 5.16% 5.53% 4.68% 6.01% 4.08% 7.07% 21.42% 25.88%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 1.10% 3.96% 2.46% 4.35%
Cost of Revenue to Revenue		 0.00% 2.44% 2.06% 1.89% 1.77% 1.05% 0.00% 2.69% 1.72% 2.49% 0.00%
SG&A Expenses to Revenue		 10.35% 8.88% 8.36% 8.00% 9.28% 9.14% 13.97% 10.75% 10.98% 12.62% 14.02%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 55.24% 47.42% 62.95% 44.76% 53.73% 40.32% 44.60% 84.11% 58.14% 61.95% 42.73%
Earnings before Interest and Taxes (EBIT)		 33 52 47 86 74 105 106 14 75 88 274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 59 86 88 134 128 159 164 66 129 145 364
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.32 1.35 1.54 1.52 1.67 1.93 2.11 1.92 1.80 1.59 2.00
Price to Tangible Book Value (P/TBV)		 1.32 1.35 1.54 1.52 1.67 1.93 2.11 1.92 1.80 1.59 2.00
Price to Revenue (P/Rev)		 4.67 5.85 6.87 7.45 9.48 9.89 10.03 8.70 12.84 20.23 21.20
Price to Earnings (P/E)		 34.40 20.85 35.29 20.19 33.42 21.82 26.81 0.00 47.47 37.08 25.19
Dividend Yield		 8.93% 6.45% 6.15% 5.88% 5.55% 5.43% 5.33% 6.54% 5.23% 4.29% 3.71%
Earnings Yield		 2.91% 4.80% 2.83% 4.95% 2.99% 4.58% 3.73% 0.00% 2.11% 2.70% 3.97%
Enterprise Value to Invested Capital (EV/IC)		 1.12 1.17 1.27 1.31 1.44 1.60 1.65 1.53 1.70 1.71 2.05
Enterprise Value to Revenue (EV/Rev)		 9.72 9.94 10.88 10.22 12.55 12.76 13.35 11.64 13.46 17.65 20.73
Enterprise Value to EBITDA (EV/EBITDA)		 12.10 12.04 16.48 12.02 15.97 14.29 15.66 32.89 20.77 27.86 21.66
Enterprise Value to EBIT (EV/EBIT)		 21.72 19.92 31.10 18.70 27.52 21.77 24.12 157.26 35.44 45.80 28.82
Enterprise Value to NOPAT (EV/NOPAT)		 21.72 19.82 31.10 19.16 28.20 21.77 24.10 125.97 33.54 49.64 36.75
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.87 16.15 16.30 16.15 16.23 15.62 16.37 15.11 17.27 16.57 20.04
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 292.25 0.00 21.20 0.00 15.10 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.50 0.99 0.94 0.64 0.60 0.60 0.74 0.85 0.42 0.14 0.22
Long-Term Debt to Equity		 1.50 0.99 0.94 0.64 0.60 0.60 0.74 0.85 0.42 0.14 0.22
Financial Leverage		 1.87 1.15 0.94 0.73 0.56 0.55 0.63 0.69 0.32 -0.09 -0.12
Leverage Ratio		 3.06 2.24 2.02 1.82 1.66 1.64 1.72 1.85 1.63 1.27 1.23
Compound Leverage Factor		 0.93 1.26 1.12 1.23 1.03 1.27 1.16 -1.00 1.16 1.79 1.46
Debt to Total Capital		 60.03% 49.85% 48.45% 38.93% 37.42% 37.38% 42.37% 45.86% 29.57% 11.93% 18.05%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 60.03% 49.85% 48.45% 38.93% 37.42% 37.38% 42.37% 45.86% 29.57% 11.93% 18.05%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.63% 0.48%
Common Equity to Total Capital		 39.97% 50.15% 51.55% 61.07% 62.58% 62.62% 57.63% 54.14% 70.34% 87.44% 81.47%
Debt to EBITDA		 6.63 5.20 6.37 3.67 4.32 3.43 4.11 10.84 4.63 2.73 2.45
Net Debt to EBITDA		 6.29 4.96 6.08 3.26 3.90 3.21 3.89 8.29 0.94 -4.21 -0.56
Long-Term Debt to EBITDA		 6.63 5.20 6.37 3.67 4.32 3.43 4.11 10.84 4.63 2.73 2.45
Debt to NOPAT		 11.89 8.57 12.01 5.85 7.63 5.22 6.32 41.53 7.47 4.87 4.16
Net Debt to NOPAT		 11.29 8.16 11.48 5.19 6.89 4.89 5.99 31.75 1.52 -7.51 -0.95
Long-Term Debt to NOPAT		 11.89 8.57 12.01 5.85 7.63 5.22 6.32 41.53 7.47 4.87 4.16
Altman Z-Score		 0.77 1.06 1.15 1.70 1.86 2.15 1.93 1.39 2.65 5.72 4.79
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.08% 0.53% 0.64%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.94 0.64 0.42 1.68 2.26 1.59 1.17 0.49 4.51 3.13 4.41
Quick Ratio		 0.81 0.58 0.39 1.43 1.53 1.06 0.88 0.26 4.18 2.81 2.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -176 -195 -204 5.49 -135 107 -22 145 -69 -714 -1,324
Operating Cash Flow to CapEx		 17.30% 23.13% 22,034.74% 0.00% 4,526.70% 8,628.48% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -7.30 -8.54 -8.44 0.20 -4.80 4.54 -0.63 4.82 -1.70 -23.06 -30.02
Operating Cash Flow to Interest Expense		 1.67 2.82 3.67 3.57 4.49 6.16 4.55 4.81 3.79 7.89 8.94
Operating Cash Flow Less CapEx to Interest Expense		 -8.00 -9.36 3.65 3.71 4.39 6.09 4.57 6.07 3.92 8.08 10.39
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.13 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.11 0.08 0.09
Accounts Receivable Turnover		 31.94 25.41 23.85 18.86 23.41 81.17 90.71 132.33 489.76 292.25 66.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.12 0.00
Accounts Payable Turnover		 0.00 0.24 0.19 0.18 0.19 0.11 0.00 0.20 0.12 0.13 0.00
Days Sales Outstanding (DSO)		 11.43 14.36 15.30 19.35 15.59 4.50 4.02 2.76 0.75 1.25 5.53
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 1,532.60 1,973.24 2,055.28 1,947.74 3,372.10 0.00 1,802.47 3,111.08 2,884.42 0.00
Cash Conversion Cycle (CCC)		 11.43 -1,518.24 -1,957.94 -2,035.93 -1,932.15 -3,367.60 4.02 -1,799.71 -3,110.34 -2,883.17 5.53
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 644 892 1,143 1,221 1,429 1,426 1,554 1,427 1,576 2,372 3,856
Invested Capital Turnover		 0.14 0.14 0.13 0.13 0.12 0.13 0.13 0.13 0.13 0.12 0.12
Increase / (Decrease) in Invested Capital		 209 248 251 78 208 -2.77 128 -127 149 796 1,539
Enterprise Value (EV)		 719 1,040 1,447 1,604 2,050 2,276 2,568 2,182 2,674 4,047 7,895
Market Capitalization		 345 612 913 1,169 1,549 1,764 1,930 1,632 2,551 4,638 8,075
Book Value per Share		 $5.45 $7.79 $7.83 $9.16 $9.71 $9.55 $9.44 $8.75 $11.89 $16.96 $18.07
Tangible Book Value per Share		 $5.45 $7.79 $7.83 $9.16 $9.71 $9.55 $9.44 $8.75 $11.89 $16.96 $18.07
Total Capital		 656 902 1,154 1,258 1,482 1,460 1,589 1,569 2,014 3,326 4,953
Total Debt		 394 450 559 490 555 546 673 719 596 397 894
Total Long-Term Debt		 394 450 559 490 555 546 673 719 596 397 894
Net Debt		 374 428 534 435 501 512 638 550 121 -612 -203
Capital Expenditures (CapEx)		 233 279 0.40 -3.99 2.79 1.69 -0.95 -38 -5.34 -5.89 -64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -13 -16 -25 -14 -1.54 -7.30 -15 -40 -47 22 213
Debt-free Net Working Capital (DFNWC)		 -1.08 -8.45 -18 23 19 12 4.42 -27 248 236 411
Net Working Capital (NWC)		 -1.08 -8.45 -18 23 19 12 4.42 -27 248 236 411
Net Nonoperating Expense (NNE)		 23 23 21 26 26 24 35 25 26 -43 -105
Net Nonoperating Obligations (NNO)		 382 439 548 453 501 512 638 578 157 -558 -203
Total Depreciation and Amortization (D&A)		 26 34 41 48 54 55 57 52 53 57 91
Debt-free, Cash-free Net Working Capital to Revenue		 -16.96% -15.23% -19.03% -8.73% -0.94% -4.09% -8.05% -21.23% -23.56% 9.63% 55.80%
Debt-free Net Working Capital to Revenue		 -1.46% -8.07% -13.84% 14.72% 11.50% 6.52% 2.30% -14.20% 124.70% 102.89% 107.79%
Net Working Capital to Revenue		 -1.46% -8.07% -13.84% 14.72% 11.50% 6.52% 2.30% -14.20% 124.70% 102.89% 107.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.26 $0.52 $0.35 $0.73 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.81 $1.57
Adjusted Weighted Average Basic Shares Outstanding		 37.38M 56.03M 72.65M 79.39M 93.09M 95.20M 96.02M 96.70M 105.96M 154.80M 203.64M
Adjusted Diluted Earnings per Share		 $0.26 $0.52 $0.35 $0.72 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.80 $1.57
Adjusted Weighted Average Diluted Shares Outstanding		 37.38M 56.03M 72.65M 79.39M 93.10M 95.21M 96.09M 96.70M 106.15M 155.17M 204.09M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.15M 66.22M 76.14M 88.85M 95.47M 95.89M 97.05M 99.51M 130.50M 187.66M 223.40M
Normalized Net Operating Profit after Tax (NOPAT)		 23 37 33 59 63 73 75 73 81 87 217
Normalized NOPAT Margin		 31.33% 35.24% 24.96% 37.35% 38.30% 41.04% 38.78% 38.75% 40.89% 37.78% 57.03%
Pre Tax Income Margin		 13.56% 28.04% 19.46% 36.91% 28.37% 45.35% 37.42% -4.00% 27.05% 54.26% 85.40%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.38 2.28 1.92 3.08 2.65 4.42 3.09 0.46 1.85 2.85 6.21
NOPAT to Interest Expense		 1.38 2.29 1.92 3.01 2.59 4.42 3.09 0.58 1.95 2.63 4.87
EBIT Less CapEx to Interest Expense		 -8.30 -9.89 1.91 3.22 2.55 4.35 3.11 1.72 1.98 3.04 7.67
NOPAT Less CapEx to Interest Expense		 -8.30 -9.88 1.91 3.15 2.49 4.35 3.12 1.84 2.08 2.82 6.33
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 217.16% 126.97% 203.24% 108.76% 173.90% 115.20% 140.01% -1,414.04% 215.06% 138.45% 82.76%
Augmented Payout Ratio		 217.16% 126.97% 203.24% 108.76% 173.90% 115.20% 140.01% -1,414.04% 215.06% 138.45% 82.76%

Quarterly Metrics And Ratios for CareTrust REIT

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 223,404,715.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 223,404,715.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.10% -6.07% 5.72% 33.63% 38.48% -50.87% 39.16% 60.48% 87.52% 74.61% 62.28%
EBITDA Growth		 56.00% 3.60% -2.40% 42.98% 61.06% -80.30% 67.40% 308.57% 145.14% 162.17% 50.46%
EBIT Growth		 125.45% 0.18% -5.66% 80.91% 106.58% -164.59% 84.54% 941.88% 194.50% 200.20% 43.00%
NOPAT Growth		 59.97% -29.18% -5.30% 180.30% 66.24% -243.33% 62.15% 587.13% 166.05% 151.26% 55.01%
Net Income Growth		 1,124.96% 82.85% 49.53% 2,252.48% 283.14% 97.59% 126.76% 551.78% 125.18% 116.07% 21.95%
EPS Growth		 700.00% 60.00% 15.79% 800.00% 162.50% 25.00% 59.09% 400.00% 66.67% 73.33% 2.86%
Operating Cash Flow Growth		 6.47% 26.46% 39.01% 66.24% 49.08% 76.25% 46.21% 90.23% 50.06% 60.83% 26.59%
Free Cash Flow Firm Growth		 -162.86% -192.32% -227.20% -649.80% -102.93% -502.20% -568.60% -682.90% -798.67% -106.13% 38.70%
Invested Capital Growth		 7.09% 10.45% 16.23% 11.95% 12.82% 50.48% 84.64% 83.18% 94.03% 66.40% 29.49%
Revenue Q/Q Growth		 8.39% -27.41% 31.90% 9.23% 12.32% -74.25% 273.61% 19.43% 20.53% 2.98% 9.48%
EBITDA Q/Q Growth		 42.67% -15.40% 41.85% -32.32% 60.72% -89.65% 1,105.28% 16.52% 10.07% 46.14% -20.77%
EBIT Q/Q Growth		 93.59% -24.69% 78.11% -48.36% 121.05% -123.54% 608.92% 15.62% 10.72% 54.59% -29.00%
NOPAT Q/Q Growth		 243.61% -46.44% 103.60% -44.24% 103.79% -146.18% 330.33% 13.00% 16.49% -0.98% 16.60%
Net Income Q/Q Growth		 1,894.42% 202.75% 9.34% -63.76% 219.41% 56.13% 25.48% 4.16% 10.35% 49.82% -29.18%
EPS Q/Q Growth		 900.00% 200.00% -8.33% -68.18% 200.00% 42.86% 16.67% 0.00% 0.00% 48.57% -30.77%
Operating Cash Flow Q/Q Growth		 41.56% -5.41% 14.41% 8.51% 26.94% 11.84% -5.09% 41.18% 0.14% 19.87% -25.29%
Free Cash Flow Firm Q/Q Growth		 -252.61% -75.48% -47.25% 13.56% 4.57% -420.73% -63.49% -4.28% -14.30% 6.89% 44.73%
Invested Capital Q/Q Growth		 0.39% 1.41% 3.34% 6.41% 1.17% 35.27% 26.79% 5.57% 7.17% 13.34% 0.98%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 97.78% 98.61% 98.77% 99.63% 95.51% 93.37% 99.86% 98.95% 99.74% 101.20% 100.00%
EBITDA Margin		 61.01% 71.10% 76.47% 49.59% 70.96% 28.51% 91.98% 89.74% 81.96% 116.31% 84.17%
Operating Margin		 45.97% 33.92% 52.36% 30.41% 55.18% -98.95% 61.00% 58.59% 57.33% 53.64% 58.76%
EBIT Margin		 36.57% 37.94% 51.23% 27.72% 54.55% -49.87% 67.94% 65.77% 60.41% 90.69% 58.81%
Profit (Net Income) Margin		 15.54% 64.82% 53.74% 15.12% 43.00% 260.71% 87.56% 76.36% 69.92% 101.72% 65.80%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.66% 98.51% 97.30% 99.11% 97.22%
Interest Burden Percent		 42.50% 170.86% 104.89% 54.55% 78.83% -522.74% 130.64% 117.87% 118.93% 113.16% 115.08%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.49% 2.70% 0.00% 2.78%
Return on Invested Capital (ROIC)		 6.42% 4.49% 6.96% 4.59% 8.98% -11.49% 6.59% 6.67% 7.22% 6.62% 7.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.27% 7.90% 7.25% 0.55% 17.23% -47.30% 352.32% -2.45% 4.87% -6.40% -3.34%
Return on Net Nonoperating Assets (RNNOA)		 1.84% 2.56% 1.48% 0.11% -1.11% 4.36% 0.87% 0.17% -0.97% 0.75% 0.09%
Return on Equity (ROE)		 8.26% 7.05% 8.44% 4.70% 7.87% -7.14% 7.46% 6.84% 6.25% 7.37% 7.17%
Cash Return on Invested Capital (CROIC)		 -0.59% -4.63% -9.85% -4.14% -3.94% -36.18% -55.20% -52.90% -56.88% -42.89% -18.76%
Operating Return on Assets (OROA)		 4.50% 4.07% 5.20% 3.09% 6.26% -4.14% 5.45% 5.07% 5.03% 8.05% 5.51%
Return on Assets (ROA)		 1.91% 6.95% 5.45% 1.69% 4.94% 21.65% 7.03% 5.89% 5.83% 9.03% 6.16%
Return on Common Equity (ROCE)		 8.25% 7.04% 8.44% 4.69% 7.86% -7.10% 7.42% 6.81% 6.23% 7.32% 7.13%
Return on Equity Simple (ROE_SIMPLE)		 3.77% 0.00% 3.78% 3.81% 4.08% 0.00% 5.49% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 26 14 28 21 43 -20 45 51 60 59 69
NOPAT Margin		 45.97% 33.92% 52.36% 30.41% 55.18% -98.95% 61.00% 57.72% 55.78% 53.64% 57.13%
Net Nonoperating Expense Percent (NNEP)		 3.15% -3.41% -0.29% 4.04% -8.25% 35.80% -345.73% 9.13% 2.35% 13.02% 10.42%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.68% 1.23% - - -0.60% 1.21% 1.19% 1.22% 1.20% 1.37%
Cost of Revenue to Revenue		 2.22% 1.39% 1.23% 0.37% 4.49% 6.63% 0.14% 1.05% 0.26% -1.20% 0.00%
SG&A Expenses to Revenue		 9.88% 16.04% 12.78% 8.91% 8.61% 46.60% 12.12% 14.11% 14.39% 14.88% 14.44%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 51.81% 64.69% 46.41% 69.22% 40.33% 192.32% 38.86% 40.35% 42.41% 47.56% 41.24%
Earnings before Interest and Taxes (EBIT)		 20 15 27 19 42 -9.94 51 58 65 100 71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 34 29 41 34 55 5.68 68 80 88 128 102
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.76 1.80 1.66 1.83 1.96 1.59 1.83 1.78 1.74 2.00 1.98
Price to Tangible Book Value (P/TBV)		 1.76 1.80 1.66 1.83 1.96 1.59 1.83 1.78 1.74 2.00 1.98
Price to Revenue (P/Rev)		 9.29 12.84 13.79 14.40 17.69 20.23 21.43 20.67 20.81 21.20 19.16
Price to Earnings (P/E)		 46.59 47.47 43.93 47.87 47.95 37.08 33.08 26.67 26.58 25.19 24.45
Dividend Yield		 5.69% 5.23% 4.84% 4.54% 3.73% 4.29% 4.22% 4.09% 3.73% 3.71% 3.81%
Earnings Yield		 2.15% 2.11% 2.28% 2.09% 2.09% 2.70% 3.02% 3.75% 3.76% 3.97% 4.09%
Enterprise Value to Invested Capital (EV/IC)		 1.52 1.70 1.65 1.91 2.30 1.71 1.79 1.81 1.85 2.05 2.04
Enterprise Value to Revenue (EV/Rev)		 11.25 13.46 13.36 13.37 15.02 17.65 21.50 20.23 18.81 20.73 18.61
Enterprise Value to EBITDA (EV/EBITDA)		 17.31 20.77 21.08 19.85 21.54 27.86 31.13 24.63 22.03 21.66 19.95
Enterprise Value to EBIT (EV/EBIT)		 28.09 35.44 36.49 29.80 30.41 45.80 48.24 34.91 30.31 28.82 26.92
Enterprise Value to NOPAT (EV/NOPAT)		 25.11 33.54 34.46 28.26 30.12 49.64 54.39 39.98 34.40 36.75 33.20
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.18 17.27 15.98 17.46 19.08 16.57 20.16 18.24 18.03 20.04 19.25
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.54 0.42 0.36 0.34 0.16 0.14 0.28 0.30 0.22 0.22 0.22
Long-Term Debt to Equity		 0.54 0.42 0.36 0.34 0.16 0.14 0.28 0.30 0.22 0.22 0.22
Financial Leverage		 0.56 0.32 0.20 0.19 -0.06 -0.09 0.00 -0.07 -0.20 -0.12 -0.03
Leverage Ratio		 1.77 1.63 1.58 1.61 1.33 1.27 1.35 1.40 1.24 1.23 1.28
Compound Leverage Factor		 0.75 2.79 1.66 0.88 1.05 -6.64 1.76 1.64 1.48 1.39 1.48
Debt to Total Capital		 34.89% 29.57% 26.23% 25.65% 14.06% 11.93% 21.81% 23.06% 18.20% 18.05% 17.72%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 34.89% 29.57% 26.23% 25.65% 14.06% 11.93% 21.81% 23.06% 18.20% 18.05% 17.72%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.06% 0.09% 0.10% 0.08% 0.09% 0.63% 0.55% 0.57% 0.47% 0.48% 0.44%
Common Equity to Total Capital		 65.05% 70.34% 73.67% 74.27% 85.85% 87.44% 77.64% 76.38% 81.33% 81.47% 81.84%
Debt to EBITDA		 4.37 4.63 4.66 4.02 2.12 2.73 4.76 4.28 3.14 2.45 2.24
Net Debt to EBITDA		 3.01 0.94 -0.69 -1.54 -3.84 -4.21 -0.02 -0.65 -2.42 -0.56 -0.65
Long-Term Debt to EBITDA		 4.37 4.63 4.66 4.02 2.12 2.73 4.76 4.28 3.14 2.45 2.24
Debt to NOPAT		 6.33 7.47 7.63 5.73 2.96 4.87 8.31 6.94 4.90 4.16 3.74
Net Debt to NOPAT		 4.37 1.52 -1.13 -2.20 -5.38 -7.51 -0.04 -1.05 -3.78 -0.95 -1.09
Long-Term Debt to NOPAT		 6.33 7.47 7.63 5.73 2.96 4.87 8.31 6.94 4.90 4.16 3.74
Altman Z-Score		 1.91 2.56 2.81 3.15 6.02 5.62 3.57 2.84 4.17 4.68 4.74
Noncontrolling Interest Sharing Ratio		 0.11% 0.08% 0.09% 0.08% 0.10% 0.53% 0.50% 0.50% 0.40% 0.64% 0.61%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.40 4.51 6.27 6.44 4.14 3.13 1.74 4.53 5.10 4.41 4.21
Quick Ratio		 0.06 4.18 5.91 6.06 3.80 2.81 1.10 3.72 4.60 2.50 3.30
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -77 -135 -199 -164 -157 -815 -1,333 -1,390 -1,589 -1,479 -818
Operating Cash Flow to CapEx		 1,635.01% 0.00% 13,869.32% 6,374.85% 0.00% 0.00% 0.00% 2,235.97% 3,124.21% 0.00% 2,859.65%
Free Cash Flow to Firm to Interest Expense		 -6.57 -16.38 -24.23 -18.91 -17.52 -159.19 -199.88 -106.62 -122.11 -130.02 -72.73
Operating Cash Flow to Interest Expense		 3.84 5.16 5.93 6.10 7.52 14.68 10.70 7.73 7.76 10.63 8.04
Operating Cash Flow Less CapEx to Interest Expense		 3.60 5.16 5.89 6.01 7.75 15.66 17.02 7.38 7.51 13.26 7.76
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.12 0.11 0.10 0.11 0.11 0.08 0.08 0.08 0.08 0.09 0.09
Accounts Receivable Turnover		 352.39 489.76 478.04 333.88 425.75 292.25 212.41 150.00 80.71 66.00 52.05
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.14 0.13 0.00 0.15 0.16 0.12 0.13 0.00 0.13 0.00 0.14
Accounts Payable Turnover		 0.12 0.12 0.11 0.09 0.13 0.13 0.12 0.08 0.03 0.00 0.00
Days Sales Outstanding (DSO)		 1.04 0.75 0.76 1.09 0.86 1.25 1.72 2.43 4.52 5.53 7.01
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 3,065.02 3,111.08 3,476.86 3,905.98 2,893.89 2,884.42 3,054.43 4,566.72 10,548.69 0.00 0.00
Cash Conversion Cycle (CCC)		 -3,063.99 -3,110.34 -3,476.10 -3,904.89 -2,893.03 -2,883.17 -3,052.71 -4,564.28 -10,544.17 5.53 7.01
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,554 1,576 1,629 1,733 1,753 2,372 3,007 3,174 3,402 3,856 3,894
Invested Capital Turnover		 0.14 0.13 0.13 0.15 0.16 0.12 0.11 0.12 0.13 0.12 0.12
Increase / (Decrease) in Invested Capital		 103 149 227 185 199 796 1,378 1,441 1,649 1,539 887
Enterprise Value (EV)		 2,360 2,674 2,692 3,310 4,040 4,047 5,380 5,740 6,279 7,895 7,950
Market Capitalization		 1,948 2,551 2,779 3,566 4,759 4,638 5,363 5,866 6,946 8,075 8,188
Book Value per Share		 $11.16 $11.89 $12.60 $13.68 $15.71 $16.96 $15.60 $17.22 $19.94 $18.07 $18.49
Tangible Book Value per Share		 $11.16 $11.89 $12.60 $13.68 $15.71 $16.96 $15.60 $17.22 $19.94 $18.07 $18.49
Total Capital		 1,706 2,014 2,272 2,617 2,821 3,326 3,770 4,321 4,911 4,953 5,049
Total Debt		 595 596 596 671 397 397 822 996 894 894 895
Total Long-Term Debt		 595 596 596 671 397 397 822 996 894 894 895
Net Debt		 411 121 -89 -258 -721 -612 -4.16 -151 -690 -203 -260
Capital Expenditures (CapEx)		 2.76 -0.01 0.35 0.83 -2.06 -5.01 -42 4.51 3.23 -30 3.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -40 -47 -48 -50 -65 22 58 79 18 213 98
Debt-free Net Working Capital (DFNWC)		 -37 248 403 445 312 236 85 385 730 411 321
Net Working Capital (NWC)		 -37 248 403 445 312 236 85 385 730 411 321
Net Nonoperating Expense (NNE)		 17 -13 -0.74 11 9.42 -72 -20 -17 -15 -53 -10
Net Nonoperating Obligations (NNO)		 443 157 -47 -213 -671 -558 59 -151 -615 -203 -260
Total Depreciation and Amortization (D&A)		 14 13 14 15 13 16 18 21 23 28 31
Debt-free, Cash-free Net Working Capital to Revenue		 -19.15% -23.56% -23.98% -20.29% -24.06% 9.63% 23.32% 27.97% 5.35% 55.80% 22.89%
Debt-free Net Working Capital to Revenue		 -17.49% 124.70% 199.93% 179.70% 116.09% 102.89% 33.91% 135.84% 218.82% 107.79% 75.13%
Net Working Capital to Revenue		 -17.49% 124.70% 199.93% 179.70% 116.09% 102.89% 33.91% 135.84% 218.82% 107.79% 75.13%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.08 $0.24 $0.22 $0.07 $0.21 $0.31 $0.35 $0.36 $0.35 $0.51 $0.36
Adjusted Weighted Average Basic Shares Outstanding		 104.01M 105.96M 132.84M 144.90M 159.46M 154.80M 187.15M 192.44M 211.75M 203.64M 223.01M
Adjusted Diluted Earnings per Share		 $0.08 $0.24 $0.22 $0.07 $0.21 $0.30 $0.35 $0.35 $0.35 $0.52 $0.36
Adjusted Weighted Average Diluted Shares Outstanding		 104.31M 106.15M 133.20M 145.26M 159.85M 155.17M 187.42M 192.85M 212.27M 204.09M 223.96M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 119.11M 130.50M 142.06M 154.21M 171.45M 187.66M 191.69M 200.30M 223.30M 223.40M 236.24M
Normalized Net Operating Profit after Tax (NOPAT)		 24 13 22 33 36 -10 32 51 60 43 69
Normalized NOPAT Margin		 42.49% 32.01% 40.24% 47.42% 46.24% -50.46% 42.70% 57.72% 56.19% 38.84% 57.13%
Pre Tax Income Margin		 15.54% 64.82% 53.74% 15.12% 43.00% 260.71% 88.76% 77.52% 71.85% 102.63% 67.68%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.74 1.86 3.33 2.20 4.72 -1.94 7.58 4.49 4.98 8.80 6.32
NOPAT to Interest Expense		 2.19 1.66 3.40 2.41 4.78 -3.85 6.81 3.94 4.59 5.20 6.14
EBIT Less CapEx to Interest Expense		 1.50 1.86 3.29 2.10 4.95 -0.96 13.90 4.14 4.73 11.43 6.04
NOPAT Less CapEx to Interest Expense		 1.95 1.67 3.36 2.32 5.01 -2.87 13.13 3.59 4.35 7.83 5.86
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 262.51% 215.06% 197.17% 186.20% 156.93% 138.45% 118.72% 98.04% 91.58% 82.76% 85.71%
Augmented Payout Ratio		 262.51% 215.06% 197.17% 186.20% 156.93% 138.45% 118.72% 98.04% 91.58% 82.76% 85.71%

Financials Breakdown Chart

Key Financial Trends

CareTrust REIT (CTRE) has delivered a notable uptrend in key metrics across the 2022–2025 time frame, highlighted by stronger quarterly earnings, improving operating cash flow, and a solid balance sheet. Below are the 8 most important takeaways for retail investors from the last four years of CTRE’s quarterly statements.

  • Net income to common shareholders rose meaningfully in 2025, with Q4 2025 net income to common at 111.29 million and diluted EPS at 0.52.
  • Operating cash flow from continuing operations improved through 2025: Q1 71.38m, Q2 100.78m, Q3 100.91m, and Q4 120.96m.
  • Free cash flow in Q4 2025 was solidly positive (about 116m) after accounting for roughly 4.98m in capital expenditures, signaling cash available for dividends or debt reduction.
  • Liquidity and capitalization look healthy: cash and equivalents of ~712.5m in Q3 2025, total assets ~5.09b, and total equity around 3.99b.
  • Debt management improved in 2025, with long-term debt decreasing from about 996.4m in Q2 2025 to 893.8m in Q3 2025.
  • Dividends per share remained fairly stable around 0.335 through 2025, providing predictable income for investors.
  • Weighted average shares outstanding rose to about 223.4 million (basic and diluted) by Q4 2025, which could modestly dilute per-share results even as earnings rise.
  • Investing activities produced sizable net cash outflows in 2025 (for example, around -560.3m in Q4 2025), reflecting portfolio expansion that pressures near-term cash despite strong operating cash flow.
05/14/26 02:39 PM ETAI Generated. May Contain Errors.

CareTrust REIT Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CareTrust REIT's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

CareTrust REIT's net income appears to be on an upward trend, with a most recent value of $320.29 million in 2025, rising from $10.03 million in 2015. The previous period was $124.40 million in 2024. See where experts think CareTrust REIT is headed by visiting CareTrust REIT's forecast page.

CareTrust REIT's total operating income in 2025 was $218.16 million, based on the following breakdown:
  • Total Gross Profit: $380.91 million
  • Total Operating Expenses: $162.75 million

Over the last 10 years, CareTrust REIT's total revenue changed from $73.99 million in 2015 to $380.91 million in 2025, a change of 414.8%.

CareTrust REIT's total liabilities were at $1.09 billion at the end of 2025, a 114.6% increase from 2024, and a 165.2% increase since 2015.

In the past 10 years, CareTrust REIT's cash and equivalents has ranged from $6.91 million in 2017 to $294.45 million in 2023, and is currently $198.04 million as of their latest financial filing in 2025.

Over the last 10 years, CareTrust REIT's book value per share changed from 5.45 in 2015 to 18.07 in 2025, a change of 231.7%.


Related Companies

Financial statements for NYSE:CTRE last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
J.P. Morgan is betting on this coin
For the first time in history, autonomous AI programs can hold, send, and receive funds — completely without h...
Crypto 101 Media | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel